Position in ABVX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$0
-$3,753,831 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
3 quarters on record
Common Shares in ABVX Over Time
Shares Held
Position Value (USD)
Derivatives in ABVX
reported options exposure · as of Jun 30, 2026CallValue
$16,657,500
CallShares
125,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ally Bridge Group (NY) LLC holds $75,058,438 across 22 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NERV |
Minerva Neurosciences, Inc.
|
2,175,802 | $12,075,701 | |
| 2 | PMN |
ProMIS Neurosciences Inc.
|
620,319 | $8,163,398 | |
| 3 | TRAX |
First Tracks Biotherapeutics, Inc.
|
284,287 | $5,719,854 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
16,493 | $4,036,991 | |
| 5 | ASMB |
Assembly Biosciences, Inc.
|
140,000 | $3,847,200 | |
| 6 | WHWK |
Whitehawk Therapeutics, Inc.
|
817,939 | $3,746,160 | |
| 7 | EWTX |
Edgewise Therapeutics, Inc.
|
83,300 | $3,384,479 | |
| 8 | CLYM |
Climb Bio, Inc.
|
249,172 | $3,249,202 |
All Filings in ABVX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,657,500 | 125,000 | Call | Sole | 2026-08-14 | |
| 2026-03-31 | $3,753,831 | 33,712 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $9,439,850 | 70,000 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||